+44 (0) 1223 737941 enquiries@cn-bio.com
  • Events
  • News
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Events
  • News
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
CN Bio
  • Home
  • CN Bio
    • The Company
    • Management Team
    • Careers
  • Organ-On-Chip
    • About Organ-On-Chip
    • Liver-On-Chip
    • Barrier Models
    • 3D Cell Culture
    • Toxicology
    • Drug Metabolism
    • Disease Modelling
  • Products & Services
    • PhysioMimix™ OOC
      • Product Information
      • Consumables
      • T12
      • LC12
    • Human Cell Referral
    • NASH Fee-For-Service
  • Resources
    • Scientific Publications
    • Brochures
    • Videos
  • Contact
Select Page

CN Bio Innovations raises $9 million USD (c. £6.9 million GBP)

by CN Bio. | Mar 2, 2020 | Press releases

Investment will support commercial development in key markets, US and Europe  Funding led by CITIC Securities Investment and supported by existing investor CN Innovations Headquarters relocated to larger premises in Cambridge Science Park, a leading UK life sciences...

Recent Posts

  • CN Bio Innovations raises $9 million USD (c. £6.9 million GBP) 2nd March 2020
  • NASH Drug Discovery Service Launched at AASLD 11th November 2019
  • Sydney’s AXT offers Organ-on-Chip systems in Asia Pacific region 1st May 2019

Categories

  • Business
  • Media Coverage
  • Press releases
Website built and designed by Website Energizers LTD | © 2020 CN Bio Innovations | Registered No. 06517359 | VAT No. 978184563 | Privacy Policy | Terms | Sitemap
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok